02:25 PM EDT, 08/14/2024 (MT Newswires) -- NeuroBo Pharmaceuticals ( NRBO ) shares were up nearly 8% in recent trading Wednesday after the company reported its Q2 results.

The company reported Q2 net loss of $1.85 per diluted share, widening from a loss of $0.15 a year earlier.

Three analysts surveyed by Capital IQ expected a loss of $1.12

The company did not report revenue for the quarter ended June 30.

NeuroBo Pharmaceuticals ( NRBO ) said it had $27.9 million in cash as of June 30 and expects its cash position to fund the company's operations into Q2 2025.

Price: 4.01, Change: +0.29, Percent Change: +7.80